Intrafusin

Intrafusin, the active ingredient in Intrafusin, is an amino acid supplement presented as a parenteral solution for intravenous use. It provides essential amino acids to support protein synthesis and metabolic needs in patients requiring parenteral nutrition.

GNH USA supplies Intrafusin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinical nutrition units worldwide, with a focus on safe handling and cold‑chain logistics where required. Our distribution network reaches major healthcare facilities across Europe, Asia and the Americas.

Intrafusin is used in parenteral nutrition to address amino acid deficiencies in clinical settings.

Critical illness: helps maintain protein balance and supports recovery in critically ill patients. Post‑operative care: provides essential amino acids to aid wound healing and tissue repair after major surgery. Severe malnutrition: supplies necessary amino acids for patients unable to meet nutritional needs orally.

Intrafusin may be associated with infusion‑related reactions and metabolic disturbances.

Common Side Effects: - Mild fever: transient elevation of body temperature during infusion. - Nausea: occasional feeling of queasiness. - Headache: mild headache reported by some patients. - Local irritation: redness or discomfort at the IV site. - Vomiting: occasional episodes of emesis. - Dizziness: light‑headed sensation during or after infusion.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hyperammonemia: elevated blood ammonia levels in susceptible individuals. - Metabolic acidosis: rare occurrence of acid‑base imbalance.

When using Intrafusin, clinicians should observe specific precautions to ensure patient safety.

Allergy assessment: verify no known hypersensitivity to any amino acid component. Renal function: monitor patients with impaired kidney function for accumulation. Electrolyte balance: check serum electrolytes before and during therapy. Metabolic monitoring: observe for signs of hyperammonemia or acid‑base disturbances. Infusion rate: administer according to recommended guidelines to minimize phlebitis. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intrafusin can interact with certain medications and clinical conditions.

Major Interactions (Avoid): - High‑dose nitrogenous waste: concurrent use with drugs that increase ammonia may exacerbate hyperammonemia. - Renal replacement therapy: may require dose adjustment or timing coordination.

Moderate Interactions (Monitor Closely): - Electrolyte‑altering agents: diuretics or potassium supplements may affect serum levels. - Insulin therapy: amino acids can influence glucose metabolism, requiring monitoring. - Other parenteral nutrition solutions: co‑administration may lead to nutrient imbalances.